Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
出版年份 2012 全文链接
标题
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
作者
关键词
-
出版物
BLOOD
Volume 120, Issue 16, Pages 3260-3270
出版商
American Society of Hematology
发表日期
2012-08-30
DOI
10.1182/blood-2011-10-386789
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
- (2009) Anne Catherine Sprynski et al. BLOOD
- Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
- (2009) D. W. McMillin et al. CANCER RESEARCH
- Multiple Myeloma
- (2009) S. Vincent Rajkumar CURRENT PROBLEMS IN CANCER
- Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line
- (2009) Shuqing Lü et al. EXPERIMENTAL HEMATOLOGY
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- Characterization of the ubiquitin–proteasome system in bortezomib-adapted cells
- (2009) T Rückrich et al. LEUKEMIA
- Proteasome inhibitors in the treatment of multiple myeloma
- (2009) J J Shah et al. LEUKEMIA
- Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
- (2009) Jacob P. Laubach et al. LEUKEMIA & LYMPHOMA
- A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data
- (2009) Nuno L. Barbosa-Morais et al. NUCLEIC ACIDS RESEARCH
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- Statistical issues in the analysis of Illumina data
- (2008) Mark J Dunning et al. BMC BIOINFORMATICS
- Proteasome Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics
- (2008) L. Wang et al. CLINICAL CANCER RESEARCH
- Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade
- (2008) R. Z. Orlowski et al. CLINICAL CANCER RESEARCH
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin-like growth factor-1 delays Fas-mediated apoptosis in human neutrophils through the phosphatidylinositol-3 kinase pathway
- (2008) Eddy Himpe et al. JOURNAL OF ENDOCRINOLOGY
- Point Mutation of the Proteasome 5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line
- (2008) S. Lu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- In vitro activity of bortezomib in cultures of patient tumour cells—potential utility in haematological malignancies
- (2008) Kristina Wiberg et al. MEDICAL ONCOLOGY
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology
- (2008) Liang-Hao Ding et al. NUCLEIC ACIDS RESEARCH
- Canonical and non-canonical JAK–STAT signaling
- (2008) Willis X. Li TRENDS IN CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search